Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021
August 5th, 2021
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Awarded CUNY COVID-19 Testing Contract
August 3rd, 2021
Applied DNA and A&E Introduce Anti-Counterfeiting Technology For Sustainable Sewing Threads
June 8th, 2021
Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort
June 7th, 2021
Applied DNA Adds First Summer Camp for safeCircle™ COVID-19 Testing
June 1st, 2021
APDN Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel
May 26th, 2021
FQ2’21 Financial Results Feature 384% Year-Over-Year Growth in Revenues
May 13th, 2021
APDN: Clarification on Newly Authorized Asymptomatic Serial Screening
May 13th, 2021
FDA Grants EUA to Applied DNA Linea™ COVID-19 Assay Kit
May 12th, 2021